George Christopher Eliades serves as Executive at Oyster Point Pharma, Inc., where they oversee executive responsibilities. Since joining the company, George Christopher Eliades has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 3, 2023 involved selling 16,863 shares valued at $0.
George Christopher Eliades currently holds 16,863 shares of Oyster Point Pharma, Inc. (OYST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Christopher Eliades has been a net neutral trader of OYST stock. They have purchased $0 and sold $0 worth of shares.
George Christopher Eliades's most recent insider trade was on Jan 3, 2023, when they sold 16,863 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 6, 2022 | OYST | $0 | Award | 3,573 | $N/A | Discretionary |
| Jun 7, 2021 | OYST | $0 | Award | 3,466 | $N/A | Discretionary |
| Apr 2, 2021 | OYST | $0 | Award | 19,935 | $N/A | Discretionary |
| Apr 2, 2021 | OYST | $0 | Award | 1,650 | $N/A | Discretionary |